Vimarsana
Biggest News Aggregation in the World

Page 13 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

Brain Chip of This Company Nearing FDA Approval. - Vimarsana News

Brain Chip of This Company Nearing FDA Approval.

Paradromics is one step closer to getting US Food and Drug Administration approval for commercial approval of its brain chip that will treat paralyzed

ONWARD Reports Q1 Business Update and Year-To-Date Highlights - Vimarsana News

ONWARD Reports Q1 Business Update and Year-To-Date Highlights

First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending... | May 16, 2023

ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury - Vimarsana News

ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury

New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™EINDHOVEN, the Netherlands, May 15, 2023 -- ONWARD Medical N.V. , the medical technology company creating... | May 15, 2023

ONWARD Medical: ONWARD Announces First-in-Human Use of ARC-IM Lead to Restore Movement and Function after Spinal Cord Injury - Vimarsana News

ONWARD Medical: ONWARD Announces First-in-Human Use of ARC-IM Lead to Restore Movement and Function after Spinal Cord Injury

New lead is purpose-designed to optimize the delivery of ONWARD ARC TherapyEINDHOVEN, the Netherlands, May 15, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company

Ultromics Granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis Detection - Vimarsana News

Ultromics Granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis Detection

The platform uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosisÂ